D-1446-2016 Class III Terminated

Recalled by Sun Pharmaceutical Industries, Inc. — Cranbury, NJ

FDA drug recall D-1446-2016 was initiated by Sun Pharmaceutical Industries, Inc. on Jun 27, 2016 and is designated Class III. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Mar 27, 2018). Affected quantity: 16,085 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 27, 2016
Initiation Date
Jun 27, 2016
Termination Date
Mar 27, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16,085 bottles

Product description

buPROPion Hydrochloride Extended Release Tablets USP (SR) 150 mg Rx Only 60 tablets Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol 389-350 Gujarat India ---- NDC 47335-737-86

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide

Code information

Lot JKN3477A, exp 07/2016

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1446-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1446-2016. Report a data issue: hello@regdatalab.com.